Magnetic Resonance Imaging in Obesity
To Investigate the Effect of Therapeutic Interventions Used in the Treatment of Obesity on Organ and Total Body Fat Measured Using MRI.
1 other identifier
observational
49
1 country
1
Brief Summary
Obesity and its related conditions account for up to 5%of all health care spending in the UK and this is expected to double by 2030. Following weight loss, significant improvement in these obesity-related illnesses has been reported. However, there is limited understanding of how these improvements happen and in particular, little dedicated work has been done using imaging in the obese population to look at the effects of treatment. Magnetic resonance imaging (MRI) is an imaging technique that allows assessment of fat concentration and volume without the use of ionising radiation. It is safe, non-invasive and well-tolerated by most patients. There are several MRI imaging techniques that be can used for fat quantification. These include MR spectroscopy and Dixon methods with measurement of fat fraction. These techniques measure the fat in the body organs and also the fat in the abdomen and skin. Recent technical developments mean that the whole body can be scanned relatively quickly (typically 30-40 minutes).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 27, 2018
CompletedFirst Posted
Study publicly available on registry
May 17, 2018
CompletedStudy Start
First participant enrolled
May 31, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 6, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 6, 2021
CompletedOctober 25, 2023
October 1, 2023
3.5 years
April 27, 2018
October 24, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
The effects of obesity treatments on individual organ using MRI
Measures are fat fraction in individual organs before and after therapeutic interventions
15 years
Secondary Outcomes (1)
Imaging measure of individual organ with metabolic markers of disease collected as part of usual care or parallel research studies.
15 years
Study Arms (3)
Patient Cohort 1
* Age 18 or over * BMI greater than or equal to 30 (greater than or equal to 27.5 for patients of Asian origin) * Due to undergo or referred for a formal treatment intervention for obesity (lifestyle modifications \[dietary change, behavioural therapy, increased physical activity\], surgical intervention or pharmacological treatment) as part of their usual clinical care * Informed written consent * Able to tolerate MRI
Patient Cohort 2
* Age 18 or over * Attending weight management service at UCLH * Informed written consent * Able to tolerate MRI
Controls
* Age 18 or over * BMI less than 25 * Informed written consent * Able to tolerate MRI
Interventions
MRI scan (not involving ionising radiation) The MRI study will be conducted by a trained MR radiographer, supervised by the nominated researcher
Student researcher or research nurses to take consent. Consent will be taken in the obesity clinic or radiology departments.
Eligibility Criteria
Patients will be recruited by suitably trained members of the research team on the study delegation log including research fellows, nurses, surgeons and endocrinologists working in a tertiary bariatric referral centre at UCLH on a person-to-person basis.
You may qualify if:
- Age 18 or over
- BMI greater than or equal to 30
- Due to undergo or referred for a formal treatment intervention for obesity, as part of their usual clinical care.
- Informed consent
- Cohort 2
- Age 18 or over
- Attending the weight management service at UCLH
- Informed consent
- Controls
- Age 18 or over
- BMI less than 25
- Informed consent
You may not qualify if:
- Absolute contraindication to MRI scan (e.g. metal foreign object)
- Unable to tolerate MRI scan (e.g. due to claustrophobia)
- MRI bore size inadequate to accommodate the patient
- Previous weight loss surgery (e.g. gastric band, gastric bypass, sleeve gastrectomy) \[Cohort 1 only\]
- Unable to give consent
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University College London Hospital
London, United Kingdom
Related Publications (4)
Reeder SB, Cruite I, Hamilton G, Sirlin CB. Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy. J Magn Reson Imaging. 2011 Oct;34(4):729-749. doi: 10.1002/jmri.22775. Epub 2011 Sep 16.
PMID: 22025886BACKGROUNDSjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lonroth H, Naslund I, Olbers T, Stenlof K, Torgerson J, Agren G, Carlsson LM; Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007 Aug 23;357(8):741-52. doi: 10.1056/NEJMoa066254.
PMID: 17715408BACKGROUNDHernando D, Sharma SD, Aliyari Ghasabeh M, Alvis BD, Arora SS, Hamilton G, Pan L, Shaffer JM, Sofue K, Szeverenyi NM, Welch EB, Yuan Q, Bashir MR, Kamel IR, Rice MJ, Sirlin CB, Yokoo T, Reeder SB. Multisite, multivendor validation of the accuracy and reproducibility of proton-density fat-fraction quantification at 1.5T and 3T using a fat-water phantom. Magn Reson Med. 2017 Apr;77(4):1516-1524. doi: 10.1002/mrm.26228. Epub 2016 Apr 15.
PMID: 27080068BACKGROUNDTakahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med. 2004 Jul-Aug;22(4):275-82.
PMID: 15468951BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 27, 2018
First Posted
May 17, 2018
Study Start
May 31, 2018
Primary Completion
December 6, 2021
Study Completion
December 6, 2021
Last Updated
October 25, 2023
Record last verified: 2023-10